Dr. Alemdar specializes in stomach cancer treatment with over 15 years of experience in oncology, trained at Akdeniz University.
Dr. Yildiz brings over a decade of specialized experience in oncology to Medipol Mega University Hospital, with a strong focus on research.
Heads the Colorectal Surgery Department at Sourasky Medical Center and is a top specialist in complex abdominal procedures.
Senior Consultant at Asklepios Hospital specializing in laparoscopic surgery for gastrointestinal conditions.
Professor Köstler is a medical oncologist specializing in personalized, targeted cancer therapies. He works at the renowned Wiener Privatklinik and the Medical University of Vienna.
Dr. Fox specializes in stomach cancer treatment, combining chemotherapy, immunotherapy, and targeted therapies for personalized care at Medical Center in Solingen.
Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.
Professor Keil specializes in advanced imaging techniques for precise stomach cancer diagnostics at Medical Center in Solingen.
Associate Professor Dr. Yusuf Acikgoz brings expertise from Ohio State University and active involvement in international clinical trials for stomach cancer.
Specialized in laparoscopic surgery for stomach cancer – trained at Istanbul University, one of Turkey's top medical schools.
Assoc. Prof. Nail Paksoy brings 14 years of oncology expertise to Medipol Bahcelievler Hospital, with a focus on advanced gastrointestinal cancers.
Dr. Ercan Ozden specializes in stomach cancer treatment with over 20 years of experience in internal medicine and oncology.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Specializes in gastric cancer surgery with broad expertise in oncological and bariatric procedures at BAH International.
Dr. Alexander Beny leads the Gastrointestinal Malignant Service at Rambam Medical Center, specializing in stomach cancer treatment.
Professor Tamar Jablonski-Perec leads oncology at Hadassah Medical Center, with training at Sloan-Kettering Cancer Center in New York.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.